Nagtegaal ID - Search Results

1

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.

Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, Gómez García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, Oláh E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ. Kempers MJ, et al. Among authors: nagtegaal id. Lancet Oncol. 2011 Jan;12(1):49-55. doi: 10.1016/S1470-2045(10)70265-5. Epub 2010 Dec 8. Lancet Oncol. 2011. PMID: 21145788 Free PMC article.

2

Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?

Bus PJ, Nagtegaal ID, Verspaget HW, Lamers CB, Geldof H, Van Krieken JH, Griffioen G. Bus PJ, et al. Among authors: nagtegaal id. Aliment Pharmacol Ther. 1999 Nov;13(11):1397-402. doi: 10.1046/j.1365-2036.1999.00652.x. Aliment Pharmacol Ther. 1999. PMID: 10571594 Free article. Clinical Trial.

3

Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers.

Nagtegaal ID, Kranenbarg EK, Hermans J, van de Velde CJ, van Krieken JH. Nagtegaal ID, et al. J Clin Oncol. 2000 Apr;18(8):1771-9. doi: 10.1200/JCO.2000.18.8.1771. J Clin Oncol. 2000. PMID: 10764439 Free article.

4

No downstaging after short-term preoperative radiotherapy in rectal cancer patients.

Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH; Pathology Review Committee and the Cooperative Clinical Investigators. Marijnen CA, et al. Among authors: nagtegaal id. J Clin Oncol. 2001 Apr 1;19(7):1976-84. doi: 10.1200/JCO.2001.19.7.1976. J Clin Oncol. 2001. PMID: 11283130 Free article. Clinical Trial.

5

High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue.

Tol J, Dijkstra JR, Vink-Börger ME, Nagtegaal ID, Punt CJ, Van Krieken JH, Ligtenberg MJ. Tol J, et al. Among authors: nagtegaal id. J Cell Mol Med. 2010 Aug;14(8):2122-31. doi: 10.1111/j.1582-4934.2009.00788.x. Epub 2010 May 13. J Cell Mol Med. 2010. PMID: 19453520 Free PMC article.

6

Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.

Koopman M, Venderbosch S, van Tinteren H, Ligtenberg MJ, Nagtegaal I, Van Krieken JH, Punt CJ. Koopman M, et al. Eur J Cancer. 2009 Jul;45(11):1999-2006. doi: 10.1016/j.ejca.2009.04.017. Epub 2009 May 18. Eur J Cancer. 2009. PMID: 19457654

7

A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

Koopman M, Venderbosch S, Nagtegaal ID, van Krieken JH, Punt CJ. Koopman M, et al. Among authors: nagtegaal id. Eur J Cancer. 2009 Jul;45(11):1935-49. doi: 10.1016/j.ejca.2009.04.023. Epub 2009 May 25. Eur J Cancer. 2009. PMID: 19473832 Review.

8

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab.

Tol J, Dijkstra JR, Klomp M, Teerenstra S, Dommerholt M, Vink-Börger ME, van Cleef PH, van Krieken JH, Punt CJ, Nagtegaal ID. Tol J, et al. Among authors: nagtegaal id. Eur J Cancer. 2010 Jul;46(11):1997-2009. doi: 10.1016/j.ejca.2010.03.036. Epub 2010 Apr 21. Eur J Cancer. 2010. PMID: 20413299 Clinical Trial.

9

Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome.

Manders P, Spruijt L, Kets CM, Willems HW, Bodmer D, Hebeda KM, Nagtegaal ID, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Manders P, et al. Among authors: nagtegaal id. Eur J Cancer. 2011 Jun;47(9):1407-13. doi: 10.1016/j.ejca.2010.12.024. Epub 2011 Jan 25. Eur J Cancer. 2011. PMID: 21273057 Free article.

10

Recurrence and variability of germline EPCAM deletions in Lynch syndrome.

Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FB, Gille JJ, Redeker B, Tops CM, van Gijn ME, van den Ouweland AM, Rahner N, Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B, Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID, van Krieken JH, Schackert HK, Hoogerbrugge N, van Kessel AG, Ligtenberg MJ. Kuiper RP, et al. Among authors: nagtegaal id. Hum Mutat. 2011 Apr;32(4):407-14. doi: 10.1002/humu.21446. Epub 2011 Mar 1. Hum Mutat. 2011. PMID: 21309036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

430 results

Search Page